Seelos Therapeutics Inc (SEEL): Asia We own the commercial rights to...

Reply Private New

Replies (1) Next 10 Prev Next

carlodb1978

Send PM Follow Ignore

Followers	4
Posts	1331
Boards Moderated	0
Alias Born	05/02/2012

carlodb1978

Re: markkind post# 14136

Monday, 03/17/2014 4:52:25 PM

Monday, March 17, 2014 4:52:25 PM

Asia

We own the commercial rights to Vitaros® in Asia including Japan and in the future will be seeking commercial partners. We have not established development or commercial plans for these regions at this time.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SEEL News

Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM

More SEEL News

InvestorsHub NewsWire

Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM

HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover